Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PIAS4 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | IL1RAP | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | SERINC2 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
mRNA | JMJD6 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | ALS2CL | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
mRNA | LIPK | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | CDH3 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
mRNA | CAPN1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
mRNA | RP11-290H9.2 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
mRNA | ANXA8L1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |